Related Experiment Video
Updated: Sep 1, 2025
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Delayed Management of Insulin-Dependent Diabetes Mellitus in Children
Emir Tas1, Katrin Wooley2, Vildan Tas3
1Emir Tas, Attending Physician, Division of Endocrinology and Diabetes, Arkansas Children's Hospital, and Assistant Professor, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR.
Insights
Delayed diagnosis of new-onset insulin-dependent diabetes mellitus (IDDM) in children leads to diabetic ketoacidosis (DKA). Improved diagnostic training for healthcare providers is crucial to prevent misdiagnosis and ensure timely IDDM management.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Diabetes Mellitus Research
Background:
- Diabetic ketoacidosis (DKA) is a frequent initial manifestation in pediatric new-onset insulin-dependent diabetes mellitus (IDDM).
- Delayed diagnosis represents the primary risk factor for DKA at the onset of IDDM.
Purpose of the Study:
- To evaluate the appropriateness of pre-hospitalization management for pediatric new-onset IDDM.
- To identify delays and misdiagnoses contributing to DKA in new-onset IDDM cases.
Main Methods:
- Retrospective review of admission records for pediatric new-onset IDDM patients.
- Independent assessment by two pediatric endocrinologists on pre-admission management.
Main Results:
- Eighteen percent of new-onset IDDM patients experienced delayed diagnosis.
- Twenty-eight patients were misdiagnosed with conditions like respiratory, genitourinary, and gastrointestinal issues.
- Mismanagement occurred in 17 patients, with 46% of delayed diagnoses presenting with DKA.
Conclusions:
- A substantial proportion of pediatric new-onset IDDM cases are misdiagnosed or mismanaged.
- Enhanced training for healthcare providers in diagnosing IDDM and adherence to clinical care standards are essential.
Introduction:
Diabetic ketoacidosis (DKA) is a common presentation for pediatric new-onset insulin-dependent diabetes mellitus (IDDM). Delayed diagnosis is the major risk factor for DKA at disease onset.
Method:
Two pediatric endocrinologists independently reviewed the admission records to assess the appropriateness of preadmission management in various health care settings.
Results:
Eighteen percent (n = 45) of patients with new-onset IDDM had a delayed diagnosis. Twenty-eight were misdiagnosed (respiratory [n = 9], nonspecific [n = 7], genitourinary [n = 4], gastrointestinal [n = 8] issues) and 17 were mismanaged. One child died within 4 hr of hospitalization, presumably because of a hyperosmolar coma. Forty-six percent (n = 21) of patients with delayed diagnosis presented with DKA, comprising 18% of all DKA cases.
Discussion:
A significant number of patients with new-onset IDDM were either misdiagnosed or mismanaged. All providers must be appropriately trained in diagnosing new-onset IDDM and follow the standard of clinical care practices.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
01:27Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...